Rationale and Design of a Multicentre, Randomized, Placebo-Controlled Trial of Mirabegron, a Beta3-Adrenergic Receptor Agonist on Left Ventricular Mass and Diastolic Function in Patients with Structural Heart Disease Beta3-Left Ventricular Hypertrophy (Beta3-Lvh)

AuthID
 P-00P-PDF
25
Author(s)
Pouleur, AC
·
Casadei, B
·
Edelmann, F
·
Filippatos, G
·
Ikonomidis, I
·
[+5]·
Pieske, B
·
Ponikowski, P
·
Senni, M
·
Trochu, JN
·
Van Overstraeten, N
·
Wachter, R
·
Balligand, JL
View all authors
Document Type
Article
Year published
2018
Published
in ESC HEART FAILURE, ISSN: 2055-5822
Volume: 5, Issue: 5, Pages: 831-842 (12)
Indexing
Wos®
Scopus®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 29932311
Scopus: 2-s2.0-85054074316
Wos: WOS:000446012000011
Source Identifiers
ISSN: 2055-5822
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.
All authors
Name Order Name   Name Order Name   Name Order Name
1 Pouleur, AC;   2 Anker, S;   3 Brito, D;
4 Brosteanu, O;   5 Hasenclever, D;   6 Casadei, B;
7 Edelmann, F;   8 Filippatos, G;   9 Gruson, D;
10 Ikonomidis, I;   11 Lhommel, R;   12 Mahmod, M;
13 Neubauer, S;   14 Persu, A;   15 Gerber, BL;
16 Piechnik, S;   17 Pieske, B;   18 Pieske Kraigher, E;
19 Pinto, F;   20 Ponikowski, P;   21 Senni, M;
22 Trochu, JN;   23 Van Overstraeten, N;   24 Wachter, R;
25 Balligand, JL;    

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service